Shenzhen New Industries Biomedical Engineering Co (SZSE:300832) YoY EBITDA Growth : 8.46% (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Shenzhen New Industries Biomedical Engineering Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Shenzhen New Industries Biomedical Engineering Co's YoY EBITDA Growth for the quarter that ended in Sep. 2024 was 8.46%.

Shenzhen New Industries Biomedical Engineering Co's EBITDA per Share for the three months ended in Sep. 2024 was ¥0.69.

Shenzhen New Industries Biomedical Engineering Co YoY EBITDA Growth Historical Data

The historical data trend for Shenzhen New Industries Biomedical Engineering Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen New Industries Biomedical Engineering Co YoY EBITDA Growth Chart

Shenzhen New Industries Biomedical Engineering Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

8.55

17.58

1.95

31.25

26.63

Shenzhen New Industries Biomedical Engineering Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
YoY EBITDA Growth	Get a 7-Day Free Trial															23.17	19.40	19.96	20.72	8.46

Shenzhen New Industries Biomedical Engineering Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Shenzhen New Industries Biomedical Engineering Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(2.606	-	2.058)	/	\| 2.058 \|
=	26.63 %

Shenzhen New Industries Biomedical Engineering Co's YoY EBITDA Growth for the quarter that ended in Sep. 2024 is calculated as:

	YoY EBITDA Growth (Q: Sep. 2024 )
=	(EBITDA per Share (Q: Sep. 2024 )	-	EBITDA per Share (Q: Sep. 2023 ))	/	\| EBITDA per Share (Q: Sep. 2023 )) \|
=	(0.692	-	0.638)	/	\| 0.638 \|
=	8.46 %

Shenzhen New Industries Biomedical Engineering Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Shenzhen New Industries Biomedical Engineering Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Shenzhen New Industries Biomedical Engineering Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shenzhen New Industries Biomedical Engineering Co Ltd (SZSE:300832) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 23, Jinxiu East Road, Kengzi Street, 21st Floor, New Industrial Bio Building, Jinsha Community, Pingshan District, Guangdong Province, Shenzhen, CHN, 518118

Website

https://www.snibe.com

Shenzhen New Industries Biomedical Engineering Co Ltd is researching, developing, producing and selling a series of fully automatic chemiluminescence immunoassay instruments and supporting reagents.

Executives

Rao Jie	Director
Liu Hai Yan	Executives
Ma Jie	Supervisors
Ding Chen Liu	Executives
Zhang Xiao Hong	Executives
Zhang Lei	Directors, executives
Li Ting Hua	Executives
Song Hong Tao	Supervisors
Liu Peng	Director
Jiang Li Li	Supervisors

Shenzhen New Industries Biomedical Engineering Co Headlines

No Headlines